The A2b adenosine receptor modulates glucose homeostasis and obesity

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Johnston Cox, Hillary ^a   Koupenova, Milka ^a   Yang, Dan ^a   Corkey, Barbara ^a   Gokce, Noyan ^a   Farb, Melissa G ^a   LeBrasseur, Nathan ^a   Ravid, Katya ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2B RECEPTOR; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; PROTEIN KINASE B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID DIET; LUNG GAS EXCHANGE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PANCREAS ISLET; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THERMOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ADENOSINE A2 RECEPTOR AGONISTS; ADULT; AMINOPYRIDINES; ANIMALS; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; HOMEOSTASIS; HUMANS; INFLAMMATION; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; OBESITY; RECEPTOR, ADENOSINE A2B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

MURINAE; MUS;

EID: 84864349274     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040584     Document Type: Article

References (55)

1. McGarry JD, (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 7-18.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D, (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes care 16: 434-444.
3. Dhaliwal SS, Welborn TA, (2009) Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores. The American journal of cardiology 103: 1403-1407.
4. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A, (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA: the journal of the American Medical Association 298: 299-308.
5. Olefsky JM, Glass CK, (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72: 219-246.
6. Yang J, Park Y, Zhang H, Xu X, Laine GA, et al. (2009) Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 296: H1850-1858.
7. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, et al. (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11: 183-190.
8. St Hilaire C, Carroll SH, Chen H, Ravid K, (2009) Mechanisms of induction of adenosine receptor genes and its functional significance. Journal of cellular physiology 218: 35-44.
9. Tucker AL, Linden J, (1993) Cloned receptors and cardiovascular responses to adenosine. Cardiovascular research 27: 62-67.
10. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J, (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacological reviews 53: 527-552.
11. Blackburn MR, Vance CO, Morschl E, Wilson CN, (2009) Adenosine receptors and inflammation. Handbook of experimental pharmacology pp. 215-269.
12. Han DH, Hansen PA, Nolte LA, Holloszy JO, (1998) Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47: 1671-1675.
13. Law WR, McLane MP, Raymond RM, (1988) Adenosine is required for myocardial insulin responsiveness in vivo. Diabetes 37: 842-845.
14. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, et al. (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nature medicine 11: 183-190.
15. Figler RA, Wang G, Srinivasan S, Jung DY, Zhang Z, et al. (2011) Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans. Diabetes 60: 669-679.
16. Shoelson SE, Lee J, Yuan M, (2003) Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27: S49-52.
17. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature medicine 1: 1155-1161.
18. Olefsky JM, (2009) IKKepsilon: a bridge between obesity and inflammation. Cell 138: 834-836.
19. Rusing D, Muller CE, Verspohl EJ, (2006) The impact of adenosine and A(2B) receptors on glucose homoeostasis. The Journal of pharmacy and pharmacology 58: 1639-1645.
20. de Luca C, Olefsky JM, (2008) Inflammation and insulin resistance. FEBS letters 582: 97-105.
21. Koupenova M, Johnston-Cox H, Vezeridis A, Gavras H, Yang D, et al. (2011) The A2b Adenosine Receptor Regulates Hyperlipidemia and Atherosclerosis. Circulation.
22. Bouzakri K, Ribaux P, Halban PA, (2009) Silencing mitogen-activated protein 4 kinase 4 (MAP4K4) protects beta cells from tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretion. The Journal of biological chemistry 284: 27892-27898.
23. Ide T, Shimano H, Yahagi N, Matsuzaka T, Nakakuki M, et al. (2004) SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nature cell biology 6: 351-357.
24. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, et al. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Molecular cell 6: 77-86.
25. Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, et al. (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. The Journal of clinical investigation 105: 199-205.
26. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391: 900-904.
27. Peng Z, Borea PA, Varani K, Wilder T, Yee H, et al. (2009) Adenosine signaling contributes to ethanol-induced fatty liver in mice. J Clin Invest 119: 582-594.
28. Boden G, Chen X, Rosner J, Barton M, (1995) Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44: 1239-1242.
29. Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ, (1998) Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. The Journal of clinical investigation 101: 1094-1101.
30. Rendell M, Hulthen UL, Tornquist C, Groop L, Mattiasson I, (2001) Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. The Journal of clinical endocrinology and metabolism 86: 744-749.
31. Despres JP, Nadeau A, Tremblay A, Ferland M, Moorjani S, et al. (1989) Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 38: 304-309.
32. Flatt JP, Ravussin E, Acheson KJ, Jequier E, (1985) Effects of dietary fat on postprandial substrate oxidation and on carbohydrate and fat balances. The Journal of clinical investigation 76: 1019-1024.
33. Grenz A, Osswald H, Eckle T, Yang D, Zhang H, et al. (2008) The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS medicine 5: e137.
34. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W, (2007) Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Archives of internal medicine 167: 1145-1151.
35. Kannel WB, McGee DL, (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA: the journal of the American Medical Association 241: 2035-2038.
36. Maeda T, Koos BJ, (2009) Adenosine A1 and A2a receptors modulate insulinemia, glycemia, and lactatemia in fetal sheep. American journal of physiology Regulatory, integrative and comparative physiology 296: R693-701.
37. Nemeth ZH, Bleich D, Csoka B, Pacher P, Mabley JG, et al. (2007) Adenosine receptor activation ameliorates type 1 diabetes. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 21: 2379-2388.
38. Peng Z, Borea PA, Varani K, Wilder T, Yee H, et al. (2009) Adenosine signaling contributes to ethanol-induced fatty liver in mice. The Journal of clinical investigation 119: 582-594.
39. Schoelch C, Kuhlmann J, Gossel M, Mueller G, Neumann-Haefelin C, et al. (2004) Characterization of adenosine-A1 receptor-mediated antilipolysis in rats by tissue microdialysis, 1H-spectroscopy, and glucose clamp studies. Diabetes 53: 1920-1926.
40. Horton JD, Goldstein JL, Brown MS, (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. The Journal of clinical investigation 109: 1125-1131.
41. Persaud SJ, Liu B, Sampaio HB, Jones PM, Muller DS, (2011) Calcium/calmodulin-dependent kinase IV controls glucose-induced Irs2 expression in mouse beta cells via activation of cAMP response element-binding protein. Diabetologia 54: 1109-1120.
42. Crespin SR, Greenough WB 3rd, Steinberg D (1973) Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect. The Journal of clinical investigation 52: 1979-1984.
43. Corkey BE, Deeney JT, Yaney GC, Tornheim K, Prentki M, (2000) The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction. The Journal of nutrition 130: 299S-304S.
44. Chen H, Yang D, Carroll SH, Eltzschig HK, Ravid K, (2009) Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury. Experimental hematology 37: 533-538.
45. Hotamisligil GS, Spiegelman BM, (1994) Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43: 1271-1278.
46. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM, (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. The Journal of clinical investigation 95: 2409-2415.
47. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, et al. (1996) IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271: 665-668.
48. Boura-Halfon S, Zick Y, (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. American journal of physiology Endocrinology and metabolism 296: E581-591.
49. Dixit VD, (2008) Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span. J Leukoc Biol 84: 882-892.
50. Hotamisligil GS, Erbay E, (2008) Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 8: 923-934.
51. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, et al. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17: 179-188.
52. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, et al. (2006) The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. The Journal of clinical investigation 116: 1913-1923.
53. Hu L, Deeney JT, Nolan CJ, Peyot ML, Ao A, et al. (2005) Regulation of lipolytic activity by long-chain acyl-coenzyme A in islets and adipocytes. American journal of physiology Endocrinology and metabolism 289: E1085-1092.
54. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, et al. (2007) Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115: 1581-1590.
55. Farb MG, Ganley-Leal L, Mott M, Liang Y, Ercan B, et al. (2011) Arteriolar Function in Visceral Adipose Tissue Is Impaired in Human Obesity. Arteriosclerosis, thrombosis, and vascular biology.